NCT02565420

Brief Summary

Perioperative volumes of saline cause a mild acidosis compared with buffered fluids. On the other hand, saline administration maintains plasma osmolality and better repletes vascular volume which is an important goal of perioperative fluid administration. Currently, there is no convincing evidence that either saline or buffered solutions are preferable. Consequently, both types of fluid remain in common use at the Clinic and worldwide. There has never been a large trial of perioperative saline and balanced salt solutions comparing the incidence of major complications including acute kidney injury. The investigators primary objective is thus to determine the relative safety of perioperative saline and lactated Ringer's solution. Specifically, the investigators propose to test the:

  1. 1.Primary hypothesis that a composite of major in-hospital postoperative complications is lower in patients given lactated Ringer's solution compared to normal saline.
  2. 2.Secondary hypothesis that acute kidney injury, measured by AKIN criteria, is lower in patients given lactated Ringer's solution compared to normal saline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,616

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

September 28, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 1, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

February 11, 2019

Status Verified

February 1, 2019

Enrollment Period

3 years

First QC Date

September 28, 2015

Last Update Submit

February 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Major Post Operative Complications

    Major complications include in-hospital mortality, renal (AKIN criteria 2+), respiratory, infectious, and hematological complications.

    After surgery through hospital discharge

Secondary Outcomes (1)

  • Economic evaluation

    After surgery through hospital discharge

Study Arms (2)

Lactated Ringer's solution

ACTIVE COMPARATOR

During the perioperative period of the colorectal, orthopedic or similar surgery the patient will receive an intervention of Lactated Ringer's solution fluids.

Other: Lactated Ringer's solution

normal saline

PLACEBO COMPARATOR

During the perioperative period of the colorectal, orthopedic or similar surgery the patient will receive an intervention of normal saline solution.

Other: Normal saline

Interventions

Patients will be administered normal saline for intraoperative fluid management.

normal saline

Patients will be administered Lactated Ringer's solution for intraoperative fluid management.

Lactated Ringer's solution

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients having colorectal or similar surgery
  • Patients having orthopedic or similar surgery
  • Patients 18 years and older

You may not qualify if:

  • Patients under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Anesthesia, Anesthesia Institute

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Postoperative Complications

Interventions

Saline SolutionRinger's Lactate

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Daniel Sessler, M.D.

    Chair, Outcomes Research

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: Alternating intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 28, 2015

First Posted

October 1, 2015

Study Start

September 28, 2015

Primary Completion

October 1, 2018

Study Completion

January 1, 2019

Last Updated

February 11, 2019

Record last verified: 2019-02

Locations